Epstein Barr virus. One herpes virus: many diseases / Volume 2, (2015)

• Record Type: Book
• Other Titles: One herpes virus: many diseases
• Further Information: Note: Christian Münz, editor.
• Editors: Münz, Christian
• Contents: Preface -- EBV latency -- Chap. 1. EBNA1 -- Lori Frappier, University of Toronto, Canada -- Chap. 2. EBNA2 and its coactivator EBNA-LP -- Bettina Kempkes, Helmholtz Center Munich, Germany, and Paul D. Ling, Baylor College of Medicine, Houston, USA -- Chap. 3. The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells- Martin J. Allday, Quentin Bazot and Robert E. White, Imperial College London, UK. Chap. 4. The latent membrane protein 1 (LMP1) -- Arnd Kieser and Kai R. Sterz, Helmholtz Center Munich, Germany. Chap. 5. Latent membrane protein 2 (LMP2) -- Osman Cen and Richard Longnecker, Northwestern University, Chicago, USA. Chap. 6. EBV non-coding RNAs -- Rebecca L. Skalsky and Bryan R. Cullen, Duke University, Durham, USA -- E. Lytic EBV infection -- 7. Viral entry -- Liudmila S. Chesnokova, Ru Jiang1 and Lindsey M. Hutt-Fletcher, Louisiana State University, Shreveport, USA -- Chap. 8. Epstein Barr virus lytic cycle reactivation -- Jessica McKenzie and Ayman El-Guindy, Yale University, New Haven, USA -- Immune responses to EBV -- Chap. 9. Innate immune recognition of EBV -- Anna Lünemann and David Nadal, University of Zürich, Switzerland and Martin Rowe, University of Birmingham, UK -- Chap. 10. Epstein-Barr virus specific humoral immune responses in health and disease -- Jaap M. Middeldorp, VU Medical Center, Amsterdam, The Netherlands -- Chap. 11. T cell responses to EBV -- Andrew D. Hislop and Graham S. Taylor, University of Birmingham, UK -- Chap. 12. Immune evasion by Epstein Barr virus -- Maaike E. Ressing, Michiel van Gent, Anna M. Gram, Marjolein Hooykaas, Sytse Piersma and Emmanuel Wiertz, Utrecht Medical Center, The Netherlands -- Animal models of EBV infection -- Chap. 13. Non-human primate lymphocryptoviruses: past, present, and future- Janine Mühe and Fred Wang, Harvard University, Boston, USA. Chap. 14. EBV infection of mice with reconstituted human immune system components -- Christian Münz, University of Zürich, Switzerland -- Therapy of EBV associated diseases -- Chap. 15. Adoptive T cell immunotherapy -- Stephen Gottschalk and Cliona Rooney, Baylor College of Medicine, Houston, USA -- Chap. 16. The Development of Prophylactic and Therapeutic EBV Vaccines -- Corey Smith and Rajiv Khanna, Queensland Institute of Medical Research, Brisbane, Australia -- Chap. 17. The biology and clinical utility of EBV monitoring in blood- Jennifer Kanakry and Richard Ambinder, Johns Hopkins University, Baltimore, USA -- Index.
• Publisher Details: Cham : Springer
• Publication Date: 2015
• Extent: 1 online resource
• Subjects: 616.99/4019; Medicine; Epstein-Barr virus; Epstein-Barr virus diseases; HEALTH & FITNESS -- Diseases -- General; MEDICAL -- Clinical Medicine; MEDICAL -- Diseases; MEDICAL -- Evidence-Based Medicine; MEDICAL -- Internal Medicine; Epstein-Barr virus; Epstein-Barr virus diseases; Medical -- Immunology; Medical -- Microbiology; Medical -- Infectious Diseases; Science -- Life Sciences -- Zoology -- General; Immunology; Medical microbiology & virology; Infectious & contagious diseases; Animal pathology & diseases; Oncology; Immunology; Medical virology; Emerging infectious diseases; Laboratory animals; Medical -- Oncology; Oncology; Electronic books
• Languages: English
• ISBNs: 9783319228341
• Related ISBNs: 331922834X; 9783319228334; 3319228331; 9783319228334
• Notes: Note: Includes bibliographical references and index.; Note: Vendor-supplied metadata.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.